US Patent Issued to ENTOS PHARMACEUTICALS on Sept. 23 for "Methods for diagnosing and treating metastatic cancer" (Canadian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,514, issued on Sept. 23, was assigned to ENTOS PHARMACEUTICALS INC. (Edmonton, Canada).

"Methods for diagnosing and treating metastatic cancer" was invented by John Lewis (Edmonton, Canada), Konstantin Stoletov (Edmonton, Canada) and Lian Willetts (Edmonton, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of diagnosing and treating metastatic cancer in a subject. The methods involve detecting or modulating the expression of at least one of Kif3b, ACTB, SRPK1, TM EM 229b, C14orf142, KB-1460A1.5, ACTC1, Nr2f1, KIAA0922, KDELR3, APBA2, miRNA 130b, miRNA 374b, or miRNA 122 in a biological sample from the subject."

The paten...